Cite
HARVARD Citation
Tan, G. et al. (n.d.). 102P A multicenter retrospective cohort study comparing the efficacy and safety of lenvatinib in combination with PD-1 inhibitor with or without transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. Immuno-oncology technology. p. . [Online].